Urica Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2021-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients with Hyperuricemia
Phase 1
Completed
- Conditions
- HyperuricemiaGout
- Interventions
- First Posted Date
- 2023-09-28
- Last Posted Date
- 2025-01-28
- Lead Sponsor
- Urica Therapeutics Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT06056570
- Locations
- 🇺🇸
Clinical Research of West Florida, Clearwater, Florida, United States
🇺🇸Panax Clinical Research, Miami Lakes, Florida, United States
🇺🇸Southwest Rheumatology Research, Mesquite, Texas, United States
News
No news found